Wromedica I Bielicka A Strzalkowska s.c.

At Wromedica I Bielicka A Strzalkowska s.c. in Wroclaw, a major share of research focuses on immune system diseases affecting the skin and joints. The site is studying conditions such as atopic dermatitis, plaque psoriasis, hidradenitis suppurativa, alopecia areata, and psoriatic arthritis, with trials aimed at evaluating new treatments, comparing effectiveness, and understanding longer-term safety.

• Research on atopic dermatitis and related eczema conditions, including studies of symptom control and treatment response
• Clinical work in plaque psoriasis and psoriatic arthritis, with attention to improving disease control and quality of life
• Trials in hidradenitis suppurativa and alopecia areata that explore new options for difficult-to-treat inflammatory skin disease

The overall goal is to assess whether emerging therapies can better manage chronic inflammatory conditions while remaining safe and well tolerated over time.

The site also contributes to research in nervous system diseases, especially multiple sclerosis. Studies include both relapsing multiple sclerosis and primary progressive multiple sclerosis, with a focus on testing treatment effectiveness, reducing relapses, and evaluating long-term safety in people living with chronic neurologic disease.

• Trials in relapsing multiple sclerosis assessing whether newer therapies can better prevent disease activity
• Studies in primary progressive multiple sclerosis aimed at comparing treatment benefits and disease control
• Long-term follow-up research designed to understand safety and durability of response in multiple sclerosis

These studies reflect an active effort to improve care for patients with progressive and relapsing forms of multiple sclerosis.

Another important area at Wromedica is nutritional and metabolic diseases, along with musculoskeletal diseases. Research includes chronic weight management and osteoporosis, supporting studies that aim to improve weight-related outcomes and strengthen bone health in adults, particularly in groups at risk for long-term complications.

• Clinical trials in chronic weight management focused on helping people achieve meaningful weight reduction
• Research in osteoporosis examining bone health and treatment comparability
• Studies that help clarify the effectiveness and safety of therapies used in metabolic and skeletal conditions

This work supports better understanding of treatments for conditions that can affect mobility, overall health, and daily functioning.

The clinical trial portfolio at this hospital/clinic includes substantial work in musculoskeletal diseases, especially rheumatoid arthritis and psoriatic arthritis. These studies are designed to compare treatment performance, evaluate symptom improvement, and follow safety over time in adults with chronic inflammatory joint disease.

• Trials in rheumatoid arthritis assessing how well new therapies control disease activity
• Studies in psoriatic arthritis looking at joint symptoms, inflammation, and treatment response
• Research focused on whether newer options can offer sustained benefit with acceptable safety

The site’s rheumatology research supports the development of better approaches for patients living with persistent pain, stiffness, and inflammation.

A large portion of the research at Wromedica I Bielicka A Strzalkowska s.c. centers on skin and connective tissue diseases. The main diseases studied include atopic dermatitis, hidradenitis suppurativa, plaque psoriasis, and alopecia areata, with trials that aim to test new therapies, compare them with existing options, and better understand long-term treatment performance.

• Studies in atopic dermatitis exploring itch, rash control, and broader symptom relief
• Research in hidradenitis suppurativa focused on reducing inflammatory skin lesions and improving disease response
• Trials in plaque psoriasis and alopecia areata assessing treatment effectiveness and durability

Overall, the site has a strong dermatology profile, with research aimed at advancing care for common and hard-to-treat chronic skin conditions.